---
category: news
title: "Lantern Pharma Receives FDA Authorization to Initiate its"
excerpt: "Lantern expects that initial patients will be enrolled into the Harmonic â„¢ trial during the third quarter of 2022. Enrollment is expected to occur over the next 12 to 16 months across multiple sites in the US."
publishedDateTime: 2022-07-14T12:25:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-lantern-pharma-receives-fda-authorization-initiate-its-phase-/2022/07/14/9638725.htm"
webUrl: "https://www.tmcnet.com/usubmit/-lantern-pharma-receives-fda-authorization-initiate-its-phase-/2022/07/14/9638725.htm"
type: article
quality: 4
heat: 4
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "yneBYMp+lVuWvGHv92opbzzllJ4c/LhT+8q/nyux0XTvjFTFToddypTJsYnMcfhXA45wtHc90MhJ/TO50i0XDwZS+uL/lP59SYNZooiSOHIaezIK8lfs/t6QlV5UPgFKUKvsrXjwmDxViVFPu2fYY4RfZKfrKQnT2vC6cTRTdQqmKMb//ajx52LpQt0StpF8NWe0i9lGP3XbFP8H/EtFuCVQTLrcbeAW2uqMj3roxDdcwFi1tdcTekX+CMthRmDBeCcyEB1G6lFNVEpxOiH0z8RqkEMOpAQMpE917h3X9OFNobnoRfX7hKi06NPeX6L2fgn5qEnjVz8TvHlE6Vp/zgwgkjXyQNr9w9Oh9JalGqU=;FfYaAUaCMDlmIhK2AuPdng=="
---

